BACR/Gordon Hamilton-Fairley Young Investigator Award
BACR1 – BACR19
- BACR1: An FGFR inhibitor prevents chemoresistance in vitro and in vivo: a novel therapy for small cell lung cancer
- BACR2: Evaluation of APC10.1 cells as an in vitro model for prediction of the ability of putative chemopreventive agents to delay adenoma development in ApcMin mice
- BACR3: C-Met oncogenic mutants sustain signals in the endosome and are protected against downregulation
- BACR4: The role of Chk1 in severe hypoxia-induced S-phase arrest
- BACR5: The mechanisms and consequences of p53 inactivation in laryngeal squamous cell carcinoma
- BACR6: NME1 and NME2 regulate activities of p53 and MDM2
- BACR7: Identification of Novel Platinum-DNA adducts formed by cisplatin
- BACR8: Prevalence of CD44+/CD24- cells associated with higher levels of anti-apoptotic protein BCl2
- BACR9: The pro-apoptotic function of p38MAPK is regulated by its ASK1-dependent sustained phosphorylation
- BACR10: Development of a novel PET probe for imaging apoptosis in vivo
- BACR11: Role of PI3K signalling pathway in modulating hypoxia response in neuroblastoma
- BACR12: Lysyl oxidase secreted by hypoxic tumour cells is critical for pre-metastatic niche formation
- BACR13: The MEK1/2 inhibitor AZD6244 (ARRY-142886) increases the therapeutic benefits of radiotherapy and inhibits the tumour hypoxia response in a lung tumour xenograft model
- BACR14: Biomarkers predicting response to neoadjuvant anthracycline chemotherapy in locally advanced primary breast cancer – 2008 update
- BACR15: PAX3 ioforms differentially regulate Notch signalling pathway in embryonic stem cells in vitro
- BACR16: Pro-angiogenic Effects of Tie-2-Expressing Monocytes in Tumours: Regulation by Angiopoietin-2 and Hypoxia
- BACR17: Inhibition of lysyl oxidase is effective against late stage metastases and increases survival in models of metastatic cancer
- BACR18: Alpha folate receptor (FOLR1) amplification and role in tumour growth independent of folate transport in ovarian cancer (EOC)
- BACR19: Expression of human embryonic stem cell genes OCT4, NANOG in breast and thyroid carcinoma compared to testicular carcinoma
